{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:15:36Z","timestamp":1791836136254,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1038\/s41416-021-01430-w","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:20:32Z","timestamp":1621495232000},"page":"458-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database"],"prefix":"10.1038","volume":"125","author":[{"given":"Kristian Hastoft","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Vogelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Ernst","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Grau","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8179","authenticated-orcid":false,"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oraloncology.2018.12.023","volume":"89","author":"ME Gaubatz","year":"2019","unstructured":"Gaubatz, M. E., Bukatko, A. R., Simpson, M. C., Polednik, K. M., Boakye, E. A., Varvares, M. A. et al. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States. Oral Oncol. 89, 95\u2013101 (2019).","journal-title":"Oral Oncol."},{"key":"1430_CR2","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/hed.25352","volume":"40","author":"SN Hamilton","year":"2018","unstructured":"Hamilton, S. N., Tran, E., Berthelet, E., Wu, J. & Olson, R. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: a population-based analysis. Head Neck 40, 2432\u20132440 (2018).","journal-title":"Head Neck"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"e0223154","DOI":"10.1371\/journal.pone.0223154","volume":"14","author":"C Talani","year":"2019","unstructured":"Talani, C., M\u00e4kitie, A., Beran, M., Holmberg, E., Laurell, G. & Farnebo, L. Early mortality after diagnosis of cancer of the head and neck \u2013 a population-based nationwide study. PLoS ONE 14, e0223154 (2019).","journal-title":"PLoS ONE"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clon.2020.07.004","volume":"33","author":"KH Jensen","year":"2021","unstructured":"Jensen, K. H., Vogelius, I., Kristensen, C. A., Andersen, E., Overgaard, J., Eriksen, J. G. et al. Early mortality after radical radiotherapy in head and neck cancer \u2013 a nationwide analysis from the Danish Head and Neck Cancer Group (DAHANCA) database. Clin. Oncol. 33, 57\u201363 (2021).","journal-title":"Clin. Oncol."},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.radonc.2013.11.009","volume":"110","author":"CR B\u00f8je","year":"2014","unstructured":"B\u00f8je, C. R., Dalton, S. O., Primdahl, H., Kristensen, C. A., Andersen, E., Johansen, J. et al. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother. Oncol. 110, 91\u201397 (2014).","journal-title":"Radiother. Oncol."},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.micinf.2015.01.004","volume":"17","author":"D Ribet","year":"2015","unstructured":"Ribet, D. & Cossart, P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 17, 173\u2013183 (2015).","journal-title":"Microbes Infect."},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.bbamem.2006.06.021","volume":"1758","author":"J Bouwstra","year":"2006","unstructured":"Bouwstra, J. & Ponec, M. The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 1758, 2080\u20132095 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"393","author":"ML Gillison","year":"2019","unstructured":"Gillison, M. L., Trotti, A. M., Harris, J., Eisbruch, A., Harari, P. M., Adelstein, D. J. et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 393, 40\u201350 (2019).","journal-title":"Lancet"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","volume":"32","author":"KK Ang","year":"2014","unstructured":"Ang, K. K., Zhang, Q., Rosenthal, D. I., Nguyen-Tan, P. F., Sherman, E. J., Weber, R. S. et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J. Clin. Oncol. 32, 2940\u20132950 (2014).","journal-title":"J. Clin. Oncol."},{"key":"1430_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","volume":"105","author":"C Terrones-Campos","year":"2019","unstructured":"Terrones-Campos, C., Ledergerber, B., Vogelius, I. R., Specht, L., Helleberg, M. & Lundgren, J. Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy. Int. J. Radiat. Oncol. 105, 812\u2013823 (2019).","journal-title":"Int. J. Radiat. Oncol."},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1567-5769(03)00013-4","volume":"3","author":"EL Verastegui","year":"2003","unstructured":"Verastegui, E. L., Morales, R. B., Barrera-Franco, J. L., Poitevin, A. C. & Hadden, J. Long-term immune dysfunction after radiotherapy to the head and neck area. Int. Immunopharmacol. 3, 1093\u20131104 (2003).","journal-title":"Int. Immunopharmacol."},{"key":"1430_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-014-0319-y","volume":"10","author":"P Ghadjar","year":"2015","unstructured":"Ghadjar, P., Hayoz, S., Zimmermann, F., Bodis, S., Kaul, D., Badakhshi, H. et al. Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: Secondary results of a randomized phase III trial (SAKK 10\/94). Radiat. Oncol. 10, 21 (2015).","journal-title":"Radiat. Oncol."},{"key":"1430_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/CLEP.S103591","volume":"8","author":"J Overgaard","year":"2016","unstructured":"Overgaard, J., Jovanovic, A., Godballe, C., Grau & Eriksen, J. The Danish Head and Neck Cancer database. Clin. Epidemiol. 8, 491\u2013496 (2016).","journal-title":"Clin. Epidemiol."},{"key":"1430_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","volume":"151","author":"K Jensen","year":"2020","unstructured":"Jensen, K., Friborg, J., R\u00f8nn, C., Sams\u00f8e, E., Johansen, J., Andersen, M. et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother. Oncol. 151, 149\u2013151 (2020).","journal-title":"Radiother. Oncol."},{"key":"1430_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","volume":"362","author":"J Overgaard","year":"2003","unstructured":"Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E. et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 362, 933\u2013940 (2003).","journal-title":"Lancet"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","volume":"46","author":"J Overgaard","year":"1998","unstructured":"Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L. et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother. Oncol. 46, 135\u2013146 (1998).","journal-title":"Radiother. Oncol."},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3109\/0284186X.2014.992547","volume":"54","author":"J Bentzen","year":"2015","unstructured":"Bentzen, J., Toustrup, K., Eriksen, J. G., Primdahl, H., Andersen, L. J. & Overgaard, J. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol. 54, 1001\u20131007 (2015).","journal-title":"Acta Oncol."},{"key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/0284186X.2019.1658897","volume":"58","author":"M Saks\u00f8","year":"2019","unstructured":"Saks\u00f8, M., Andersen, E., Bentzen, J., Andersen, M., Johansen, J., Primdahl, H. et al. A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma. Acta Oncol. 58, 1495\u20131501 (2019).","journal-title":"Acta Oncol."},{"key":"1430_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/0284186X.2012.741324","volume":"52","author":"A Pagh","year":"2013","unstructured":"Pagh, A., Vedtofte, T., Lynggaard, C. D., Rubek, N., Lonka, M., Johansen, J. et al. The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA. Acta Oncol. 52, 277\u2013284 (2013).","journal-title":"Acta Oncol."},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen, C. B. The Danish civil registration system. Scand. J. Public Health 39, 22\u201325 (2011).","journal-title":"Scand. J. Public Health"},{"key":"1430_CR21","unstructured":"PERSIMUNE. PERSIMUNE data sources (accessed 1 November 2020); http:\/\/www.persimune.dk\/How-to-get-involved\/PERSIMUNE-data-sources."},{"key":"1430_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fonc.2017.00089","volume":"7","author":"OM Maria","year":"2017","unstructured":"Maria, O. M., Eliopoulos, N. & Muanza, T. Radiation-induced oral mucositis. Front. Oncol. 7, 89 (2017).","journal-title":"Front. Oncol."},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","volume":"6","author":"FN Bray","year":"2016","unstructured":"Bray, F. N., Simmons, B. J., Wolfson, A. H. & Nouri, K. Acute and chronic cutaneous reactions to ionizing radiation therapy. Dermatol Ther. 6, 185\u2013206 (2016).","journal-title":"Dermatol Ther."},{"key":"1430_CR24","first-page":"141","volume":"5","author":"OO Aalen","year":"1978","unstructured":"Aalen, O. O. & Johansen, S. An empirical transition matrix for non-homogeneous markov chains based on censored observations. Scand. J. Stat. 5, 141\u2013150 (1978).","journal-title":"Scand. J. Stat."},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/atm.2016.08.62","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. Survival analysis in the presence of competing risks. Ann. Transl. Med. 5, 47 (2017).","journal-title":"Ann. Transl. Med."},{"key":"1430_CR26","first-page":"457","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete samples. J. ASA 53, 457\u2013481 (1958).","journal-title":"J. ASA"},{"key":"1430_CR27","unstructured":"R Foundation. The R Project for Statistical Computing (accessed 1 November 2020); https:\/\/www.r-project.org\/."},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1469-0691.12144","volume":"19","author":"KB Laupland","year":"2013","unstructured":"Laupland, K. B. Incidence of bloodstream infection: a review of population-based studies. Clin. Microbiol. Infect. 19, 492\u2013500 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"1430_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/cc10036","volume":"15","author":"M Magret","year":"2011","unstructured":"Magret, M., Lisboa, T., Martin-loeches, I., M\u00e1\u00f1ez, R., Nauwynck, M., Wrigge, H. et al. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit. Care 15, R62 (2011).","journal-title":"Crit. Care"},{"key":"1430_CR30","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3346\/jkms.2012.27.11.1308","volume":"27","author":"DW Park","year":"2012","unstructured":"Park, D. W., Chun, B. C., Choi, Y. H. & Choi, J. Y. Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 University Hospitals in Korea. J. Korean Med. Sci. 27, 1308\u20131314 (2012).","journal-title":"J. Korean Med. Sci."},{"key":"1430_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.chest.2019.10.006","volume":"157","author":"C Forstner","year":"2020","unstructured":"Forstner, C., Patchev, V., Rohde, G., Rupp, J. & Witzenrath, M. Rate and predictors of bacteremia in afebrile community-acquired pneumonia. Chest 157, 529\u2013539 (2020).","journal-title":"Chest"},{"key":"1430_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12094-018-1905-5","volume":"21","author":"M Mar\u00edn","year":"2019","unstructured":"Mar\u00edn, M., Gudiol, C., Castet, F., Oliva, M., Peir\u00f3, I., Royo-Cebrecos, C. et al. Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era. Clin. Transl. Oncol. 21, 187\u2013196 (2019).","journal-title":"Clin. Transl. Oncol."},{"key":"1430_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ajic.2015.09.011","volume":"44","author":"S L\u00f8nberg","year":"2016","unstructured":"L\u00f8nberg, S., Touborg, A., Dmsc, L., J\u00f8rn, H., Dmsc, K., Gorm, T. et al. The daily risk of bacteremia during hospitalization and associated 30-day mortality evaluated in relation to the traditional classification of bacteremia. Am. J. Infect. Control 44, 167\u2013172 (2016).","journal-title":"Am. J. Infect. Control"},{"key":"1430_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12941-016-0122-8","volume":"15","author":"M Yilmaz","year":"2016","unstructured":"Yilmaz, M., Elaldi, N., Balkan, \u0130. \u0130., Arslan, F., Bat\u0131rel, A. A. & Bak\u0131c\u0131, M. Z. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann. Clin. Microbiol. Antimicrob. 15, 7 (2016).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"1430_CR35","doi-asserted-by":"publisher","first-page":"789.e1","DOI":"10.1016\/j.cmi.2015.05.018","volume":"21","author":"M S\u00f8gaard","year":"2015","unstructured":"S\u00f8gaard, M., Thomsen, R. W., Bang, R. B., Sch\u00f8nheyder, H. C. & N\u00f8rgaard, M. Trends in length of stay, mortality and readmission among patients with community-acquired bacteraemia. Clin. Microbiol. Infect. 21, 789.e1\u2013789.e7 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1430_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3201\/eid2505.181733","volume":"25","author":"L Thorlacius-Ussing","year":"2019","unstructured":"Thorlacius-Ussing, L., Sandholdt, H., Larsen, A. R., Petersen, A. & Benfield, T. Age-dependent increase in incidence of staphylococcus aureus bacteremia, Denmark, 2008\u20132015. Emerg. Infect. Dis. 25, 875\u2013882 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"1430_CR37","unstructured":"Petersen, A., Skov, R. L., Larsen, A. R., Benfield, T., Sch\u00f8nheyder, H. C., Westh, H. et al. Staphylococcus aureus Bacteraemia. Cases in Denmark 2019 (accessed 1 November 2020); https:\/\/antibiotika.ssi.dk\/-\/media\/c18eeffa58d1498ebd8fc7788bdebaf7."},{"key":"1430_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.radonc.2017.10.018","volume":"126","author":"P Lassen","year":"2018","unstructured":"Lassen, P., Lacas, B., Pignon, J. P., Trotti, A., Zackrisson, B., Zhang, Q. et al. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: the MARCH-HPV project. Radiother. Oncol. 126, 107\u2013115 (2018).","journal-title":"Radiother. Oncol."},{"key":"1430_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.06.035","volume":"96","author":"C Gr\u00f8nh\u00f8j","year":"2019","unstructured":"Gr\u00f8nh\u00f8j, C., Jakobsen, K. K., Kj\u00e6r, E., Friborg, J. & von Buchwald, C. Comorbidity in HPV+ and HPV\u2212 oropharyngeal cancer patients: a population-based, case-control study. Oral Oncol. 96, 1\u20136 (2019).","journal-title":"Oral Oncol."},{"key":"1430_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/annonc\/mdn655","volume":"20","author":"M Moreau","year":"2009","unstructured":"Moreau, M., Klastersky, J., Schwarzbold, A., Muanza, F., Georgala, A., Aoun, M. et al. A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Ann. Oncol. 20, 513\u2013519 (2009).","journal-title":"Ann. Oncol."},{"key":"1430_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/annonc\/mdj092","volume":"17","author":"Y Lalami","year":"2006","unstructured":"Lalami, Y., Paesmans, M., Muanza, F., Barette, M., Plehiers, B., Dubreucq, L. et al. Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis. Ann. Oncol. 17, 507\u2013514 (2006).","journal-title":"Ann. Oncol."},{"key":"1430_CR42","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B. et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 350, 1937\u20131944 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1430_CR43","doi-asserted-by":"publisher","first-page":"344.e13","DOI":"10.1016\/j.cmi.2014.11.018","volume":"21","author":"S Gubbels","year":"2015","unstructured":"Gubbels, S., Nielsen, J., Voldstedlund, M., Kristensen, B., Sch\u00f8nheyder, H. C. & Arpi, M. Utilization of blood cultures in Danish hospitals: a population-based descriptive analysis. Clin. Microbiol. Infect. 21, 344.e13\u2013344.e21 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1430_CR44","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00520-011-1353-z","volume":"20","author":"CI Kang","year":"2012","unstructured":"Kang, C. I., Song, J. H., Chung, D. R., Peck, K. R., Yeom, J. S., Son, J. S. et al. Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support. Care Cancer 20, 2371\u20132378 (2012).","journal-title":"Support. Care Cancer"},{"key":"1430_CR45","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1007\/s00520-018-4275-1","volume":"26","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla, O. Y., Bahena-Lopez, J. P., Garciadiego-Fosass, P., Volkow, P., Garcia-Horton, A., Velazquez-Acosta, C. et al. Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study. Support. Care Cancer 26, 4057\u20134065 (2018).","journal-title":"Support. Care Cancer"},{"key":"1430_CR46","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30S","author":"J Klastersky","year":"2007","unstructured":"Klastersky, J., Ameye, L., Maertens, J., Georgala, A., Muanza, F., Aoun, M. et al. Bacteraemia in febrile neutropenic cancer patients. Int. J. Antimicrob. Agents 30S, S51\u2013S59 (2007).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1430_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","volume":"57","author":"M Hurst","year":"1999","unstructured":"Hurst, M., Lamb, H. M., Scott, L. J. & Figgitt, D. P. Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 57, 805\u2013843 (1999).","journal-title":"Drugs"},{"key":"1430_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"A Hassoun","year":"2017","unstructured":"Hassoun, A., Linden, P. K. & Friedman, B. Incidence, prevalence, and management of MRSA bacteremia across patient populations\u2014a review of recent developments in MRSA management and treatment. Crit. Care 21, 211 (2017).","journal-title":"Crit. Care"},{"key":"1430_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.diagmicrobio.2016.08.020","volume":"86","author":"C-H Yo","year":"2016","unstructured":"Yo, C.-H., Lee, M.-T. G., Hsein, Y.-C. & Lee, C.-C. Risk factors and outcomes of afebrile bacteremia patients in an emergency department. Diagn. Microbiol. Infect. Dis. 86, 455\u2013459 (2016).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"1430_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejca.2019.02.013","volume":"113","author":"JC Ham","year":"2019","unstructured":"Ham, J. C., Driessen, C. M., Hendriks, M. P., Fiets, E., Kreike, B., Hoeben, A. et al. Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: a randomised phase 2 study. Eur. J. Cancer 113, 32\u201340 (2019).","journal-title":"Eur. J. Cancer"},{"key":"1430_CR51","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","volume":"18","author":"B Lacas","year":"2017","unstructured":"Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Gr\u00e9goire, V., Nankivell, M. et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 18, 1221\u20131237 (2017).","journal-title":"Lancet Oncol."},{"key":"1430_CR52","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/512197","volume":"7","author":"B Lassmann","year":"2007","unstructured":"Lassmann, B., Gustafson, D. R., Wood, C. M. & Rosenblatt, J. E. Reemergence of anaerobic bacteremia. Clin. Infect. Dis. 7, 895\u2013900 (2007).","journal-title":"Clin. Infect. Dis."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01430-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:16:42Z","timestamp":1658330202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01430-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01430-w","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by relevant Danish Authorities (the Danish Data Protection Agency (#P-2020-526) and the Danish Patient Safety Authority (#3-3013-2789\/1)). In Denmark, individual patient consent is not needed for register-based studies. The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript does not include any individual person\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Unfortunately, the data supporting the results are not available for sharing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"J.F. and I.V. have received grants from the Varian Research Foundation with no influence on the submitted work. The remaining authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was funded by the Danish Comprehensive Cancer Center\u2014Radiotherapy, the Faculty of Health Science at the University of Copenhagen, Varian Research Foundation, the Department of Oncology, Rigshospitalet, Copenhagen University Hospital, and the Dagmar Marshall, Einar Willumsen, Else & Mogens Wedell-Wedellsborg and A.P. Moller foundations. The funding sources had no influence on study conceptualisation, data gathering, data analysis or manuscript preparation. The study was supported by PERSIMUNE through grant number DNRF126.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}